Graft-versus-host disease cost-effectiveness of therapy: Difference between revisions
Shyam Patel (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Cost-effectiveness of therapy focuses on the use of balance of medical expenses and therapeutic efficacy. In the case of GvHD therapy, corticosteroids are the least expensive treatment option, and alternative immunosuppressants or biologics are more expensive. | |||
==Cost-Effectiveness of Therapy== | ==Cost-Effectiveness of Therapy== | ||
Revision as of 02:06, 5 July 2017
|
Graft-versus-host disease |
|
Differentiating Graft-versus-host disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Graft-versus-host disease cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Graft-versus-host disease cost-effectiveness of therapy |
|
FDA on Graft-versus-host disease cost-effectiveness of therapy |
|
CDC on Graft-versus-host disease cost-effectiveness of therapy |
|
Graft-versus-host disease cost-effectiveness of therapy in the news |
|
Blogs on Graft-versus-host disease cost-effectiveness of therapy |
|
Risk calculators and risk factors for Graft-versus-host disease cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]
Overview
Cost-effectiveness of therapy focuses on the use of balance of medical expenses and therapeutic efficacy. In the case of GvHD therapy, corticosteroids are the least expensive treatment option, and alternative immunosuppressants or biologics are more expensive.
Cost-Effectiveness of Therapy
Corticosteroids are the most cost-effective therapy for GvHD. Prednisone and methylprednisolone are available at very low cost. Second-line therapies and cell-based therapies are significantly more expensive. If corticosteroids can be used, these should be given first.